Dr. Wyne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
543 Taylor Ave
Columbus, OH 43203Phone+1 614-685-3333Fax+1 614-366-0345
Summary
- Dr. Kathleen Wyne is an endocrinologist in Columbus, OH and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. She received her medical degree from University of Chicago Pritzker School of Medicine and has been in practice 27 years. She specializes in diabetes and lipid metabolism and is experienced in hypertension, type 1 diabetes mellitus (T1D), CFRD, and lipid metabolism disorders.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1997
- Baylor College of MedicineResidency, Internal Medicine, 1990 - 1993
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1990
- University of ChicagoPh.D., Pathology, 1985 - 1988
- University of ChicagoM.S., Human Biology, 1983 - 1985
- University of ChicagoB.A., Biology, With honors, 1979 - 1983
Certifications & Licensure
- TX State Medical License 1993 - 2026
- OH State Medical License 2014 - 2025
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Top Doctors, Endocrinology, Diabetes & Metabolism Columbus Monthly Magazine, 2015-2018
- Columbus Monthly Top Doctors Castle Connolly, 2015
- Top Doctors:SE Texas Castle Connolly, 2013
- Join now to see all
Clinical Trials
- TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) Start of enrollment: 2011 Jul 22
- A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD) Start of enrollment: 2016 Jul 01
Publications & Presentations
PubMed
- 31 citationsThiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPARγ agonismChetan B. Patel, James A. de Lemos, Kathleen Wyne, Darren K. McGuire
Diabetes & Vascular Disease Research. 2006-09-01 - 667 citationsAMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASEPaul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, Zachary T. Bloomgarden, Vivian Fonseca
Endocrine Practice. 2017-04-24 - 120 citationsConsensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of ...Yehuda Handelsman, Paul S. Jellinger, Chris K. Guerin, Zachary T. Bloomgarden, Eliot A. Brinton
Endocrine Practice. 2020-10-01
Journal Articles
- American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Testosterone and Cardiovascular RiskGoodman N, Guay A, Dandona P, Dhindsa S, Faiman C, Cunningham GR; AACE Reproductive Endocrinology Scientific Committee, Endocr Pract, 1/1/2015
- What is the role of glucose control in the prevention of cardiovascular disease in type 2 diabetes?Wyne KL, Practical Diabetology, 1/1/2015
- The world and lipidology as it relates to caGill EA, Wyne KL, Ballantyne CM, Cardiol Clin, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- What is the Optimal Waist-to-Height Ratio for Predicting CardioMetabolic Risk in Children?Shan DK, Guerra R, Wyne KL, American Society for Preventive Cardiology, 4th Annual Cardiovascular Disease Prevention Conference, Boca Raton, FL, 1/1/2015
- Is 0.5 the Optimal Waist-to-Height Ratio for Predicting Cardio-Metabolic Risk in Children?Shan DK, Guerra R, Wyne KL, National Lipid Association Annual Scientific Sessions, Chicago, IL, 1/1/2015
- Effect of Canagliflozin on Triglyceride/High-Density Lipoprotein-C: A Marker of Insulin Resistance in Patients With Type 2 Diabetes MellitusWyne KL, Ziboh A, Vijapurkar U, Davies M, Meininger G, American College of Cardiology 64th Annual Scientific Session and Expo, San Diego, CA, 1/1/2015
- Join now to see all
Lectures
- Application of New Lipid Guidelines to Clinical Practice: Evidence and ControversiesColumbus, OH - 1/20/2016
- Primary HyperaldosteronismAlexandria, Egypt - 1/12/2016
- Subclinical Cushing’sAlexandria, Egypt - 1/11/2016
- Join now to see all
Other
- The influence of lipoproteins on synthesis of apolipoprotein E by rat ovarian granulosa cellsOlson L, Wyne KL, Schmit V, Gong E, Getz G and Schreiber JR, Regulatory Processes and Gene Expression in the Ovary, ed. G Gibori, Serono Symposium
1/1/1990 - Doctoral Thesis: The Regulation of Apolipoprotein E Synthesis in Rat Ovarian Granulosa CellsWyne KL
1/1/1988 - Master’s Paper: Characterization of the Apolipoprotein E Secretion Product from Rat Ovarian Granulosa CellsWyne KL
1/1/1985
Press Mentions
- Type 1 Diabetes: Researchers Urge More Guidance on Diet, ExerciseFebruary 13th, 2023
- Type 1 Diabetes: The Benefits and Limitations of a Pancreas TransplantNovember 15th, 2022
- The #1 Cause of Diabetes, According to PhysiciansJuly 6th, 2022
- Join now to see all
Committees
- member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
- member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
- member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015
Professional Memberships
- Fellow
- Member
- European Association for the Study of Diabetes (EASD)Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: